1. A Phase IIa Study Evaluating Safety, Pharmacokinetics, and Antiviral Activity of GSK2838232, a Novel, Second-generation Maturation Inhibitor, in Participants With Human Immunodeficiency Virus Type 1 Infection. (26th November 2019) Authors: DeJesus, Edwin; Harward, Sara; Jewell, Roxanne C; Johnson, Mark; Dumont, Etienne; Wilches, Viviana; Halliday, Fiona; Talarico, Christine L; Jeffrey, Jerry; Gan, Jianjun; Xu, Jianfeng; Felizarta, Franco; Scribner, Anita; Ramgopal, Moti; Benson, Paul; Johns, Brian A Journal: Clinical infectious diseases Issue: Volume 71:Number 5(2020) Page Start: 1255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brief Report: Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients. (15th December 2015) Authors: Walmsley, Sharon; Baumgarten, Axel; Berenguer, Juan; Felizarta, Franco; Florence, Eric; Khuong-Josses, Marie-Aude; Kilby, J. Michael; Lutz, Thomas; Podzamczer, Daniel; Portilla, Joaquin; Roth, Norman; Wong, Deborah; Granier, Catherine; Wynne, Brian; Pappa, Keith Journal: Journal of acquired immune deficiency syndromes Issue: Volume 70:Number 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long‐term follow‐up study. (14th March 2022) Authors: Poordad, Fred; Felizarta, Franco; Yao, Betty B.; Overcash, J. Scott; Hassanein, Tarek; Agarwal, Kosh; Gane, Edward; Shaw, David; Waters, Michael; Krishnan, Preethi; Topp, Andrew; Burroughs, Margaret; Nevens, Frederik Journal: Liver international Issue: Volume 42:Number 6(2022) Page Start: 1278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment. Issue 2 (10th April 2017) Authors: Poordad, Fred; Felizarta, Franco; Asatryan, Armen; Sulkowski, Mark S.; Reindollar, Robert W.; Landis, Charles S.; Gordon, Stuart C.; Flamm, Steven L.; Fried, Michael W.; Bernstein, David E.; Lin, Chih‐Wei; Liu, Ran; Lovell, Sandra S.; Ng, Teresa I.; Kort, Jens; Mensa, Federico J. Journal: Hepatology Issue: Volume 66:Issue 2(2017) Page Start: 389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial. Issue 10 (October 2017) Authors: Forns, Xavier; Lee, Samuel S; Valdes, Joaquin; Lens, Sabela; Ghalib, Reem; Aguilar, Humberto; Felizarta, Franco; Hassanein, Tarek; Hinrichsen, Holger; Rincon, Diego; Morillas, Rosa; Zeuzem, Stefan; Horsmans, Yves; Nelson, David R; Yu, Yao; Krishnan, Preethi; Lin, Chih-Wei; Kort, Jens J; Mensa, Fe... Journal: Lancet infectious diseases Issue: Volume 17:Issue 10(2017:Oct.) Page Start: 1062 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial. Issue 2 (4th January 2018) Authors: Wyles, David; Poordad, Fred; Wang, Stanley; Alric, Laurent; Felizarta, Franco; Kwo, Paul Y.; Maliakkal, Benedict; Agarwal, Kosh; Hassanein, Tarek; Weilert, Frank; Lee, Samuel S.; Kort, Jens; Lovell, Sandra S.; Liu, Ran; Lin, Chih‐Wei; Pilot‐Matias, Tami; Krishnan, Preethi; Mensa, Federico J. Journal: Hepatology Issue: Volume 67:Issue 2(2018) Page Start: 514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure. Issue 4 (30th January 2018) Authors: Poordad, Fred; Pol, Stanislas; Asatryan, Armen; Buti, Maria; Shaw, David; Hézode, Christophe; Felizarta, Franco; Reindollar, Robert W.; Gordon, Stuart C.; Pianko, Stephen; Fried, Michael W.; Bernstein, David E.; Gallant, Joel; Lin, Chih‐Wei; Lei, Yang; Ng, Teresa I.; Krishnan, Preethi; Kopecky‐Br... Journal: Hepatology Issue: Volume 67:Issue 4(2018) Page Start: 1253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long‐term safety and efficacy results in hepatitis C virus genotype 1‒infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ‐I and TOPAZ‐II trials. Issue 5 (17th February 2020) Authors: Poordad, Fred; Castro, RuiSarmento E.; Asatryan, Armen; Aguilar, Humberto; Cacoub, Patrice; Dieterich, Douglas; Marinho, Rui Tato; Carvalho, Armando; Siddique, Asma; Hu, Yiran Bonnie; Charafeddine, Mariem; Bondin, Mark; Khan, Nader; Cohen, Daniel E.; Felizarta, Franco Journal: Journal of viral hepatitis Issue: Volume 27:Issue 5(2020) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Overall safety profile of boceprevir plus peginterferon alfa‐2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials. (9th October 2013) Authors: Manns, Michael P.; McCone, Jonathan; Davis, Mitchell N.; Rossaro, Lorenzo; Schiff, Eugene; Shiffman, Mitchel L.; Bacon, Bruce; Bourliere, Marc; Sulkowski, Mark S.; Bruno, Savino; Balart, Luis; Bronowicki, Jean‐Pierre; Kwo, Paul; Poordad, Fred; Felizarta, Franco; Reddy, K. Rajender; Helmond, Frans... Journal: Liver international Issue: Volume 34:Number 5(2014:Jun.) Page Start: 707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults. (24th December 2019) Authors: Letendre, Scott L; Mills, Anthony; Hagins, Debbie; Swindells, Susan; Felizarta, Franco; Devente, Jerome; Bettacchi, Christopher; Lou, Yu; Ford, Susan; Sutton, Kenneth; Shaik, Jafar Sadik; Crauwels, Herta; D'Amico, Ronald; Patel, Parul Journal: Journal of antimicrobial chemotherapy Issue: Volume 75:Number 3(2020) Page Start: 648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗